Mahmoud Maassarani, Ph.D is our man! He's the primary researcher running both clinical studies in Lebanon (total knee replacement).
My personal assumption - I can't imagine Dr. Maassarani would initiate a new Cesarean clinical study using RecoverRx without having confidence in the device's efficacy (maybe indicating positive results from the total knee replacement study, which was started back in Dec 2017?).
Thanks Pashka, 250 patients is much larger than any of BIEL's previous Clinicals. It will carry a lot more weight than the typical 30-60 subject Trials.